References
- Glimelius B. Rectal cancer irradiation. Long course, short course or something else?. Acta Oncol 2006; 45: 1013–7
- Brooks S, Glynn-Jones R, Novell R, Harrison M, Brown K, Makris A. Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer. Acta Oncol 2006; 45: 1079–85
- Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors have high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002; 52: 6–13
- Wang JZ, Li XA, Yu CX, DiBiase SJ. The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us. Int J Radiat Oncol Biol Phys 2003; 57: 1101–8
- Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005; 44: 265–76
- Whelan T, Mackenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002; 94: 1143–50
- Courdi A, Ortholan C, Hannoun-Lévi JM, Ferrero JM, Largillier R, Balu-Maestro C, et al. Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. Radiother Oncol 2006; 79: 156–61